China's Health System and Market Opportunities

The New England Healthcare Executives Network presents a morning of networking and panel discussions on opportunities for western companies in China's medical technology sector. 

Program Overview 

China is one of the largest and fastest growing economies in the world today. Despite the current market turmoil with a growing middle class and the government dedicated to improving the quality of health care, significant opportunities exist for pharmaceutical and medtech companies willing to invest the time and resources for sales growth in the coming years.

Who should attend:
CEOs, CFOs, International Sales & Regulatory Managers and companies seeking a better understand of expanding their marketing reach into China.

What to expect:
This panel will present to the audience an overview of the healthcare reform effort currently emerging in China.

Topics to be covered:

• Overview of China Healthcare Structure, needs and Business Entry Process,
• China's Healthcare Growth and Market Opportunities
• 2020 Health Initiatives
• China medtech landscape
• Funding and investment opportunities for U.S. companies in China
• CFDA Regulatory Changes and Trends
• Should you be concerned about your IP

The program will be moderated by Grace Fu Palma, CEO of China Med Device. Dezan Shira & Associates' North America Director Richard Cant will present on the panel. Joining him will be Feng Jiang, Executive Chairman & CEO of China Association of Medical Devices Industry, Bill Putnam, Principle of Imagine Access, and Chao Xu, Managing Director, Europe Branch, of OSMUNDA Medical Device Service Group.

If you would like to attend, click here.